 Connection
Michelle Barron to Treatment Outcome
This is a "connection" page, showing publications Michelle Barron has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.125 |
|
|
|
-
Barron MA, Woods PA, Campbell G, Madinger NE. Septic platelet-transfusion reactions due to methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol. 2009 Jan; 30(1):98-100.
Score: 0.031
-
Mann S, Tobolowsky F, Purohit S, Henao-Mart?nez A, Bajrovic V, Ramanan P, Wolfel E, Khazanie P, Barron M, Madinger N, Benamu E. Cryptococcal pericarditis in a heart transplant recipient. Transpl Infect Dis. 2020 Dec; 22(6):e13366.
Score: 0.017
-
Lodise TP, Rosenkranz SL, Finnemeyer M, Evans S, Sims M, Zervos MJ, Creech CB, Patel PC, Keefer M, Riska P, Silveira FP, Scheetz M, Wunderink RG, Rodriguez M, Schrank J, Bleasdale SC, Schultz S, Barron M, Stapleton A, Wray D, Chambers H, Fowler VG, Holland TL. The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE). Clin Infect Dis. 2020 04 10; 70(8):1536-1545.
Score: 0.017
-
Miller MA, Fish DN, Barber GR, Barron MA, Goolsby TA, Moine P, Mueller SW. A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections. J Microbiol Immunol Infect. 2020 Apr; 53(2):321-327.
Score: 0.015
-
Ostrosky-Zeichner L, Shoham S, Vazquez J, Reboli A, Betts R, Barron MA, Schuster M, Judson MA, Revankar SG, Caeiro JP, Mangino JE, Mushatt D, Bedimo R, Freifeld A, Nguyen MH, Kauffman CA, Dismukes WE, Westfall AO, Deerman JB, Wood C, Sobel JD, Pappas PG. MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting. Clin Infect Dis. 2014 May; 58(9):1219-26.
Score: 0.011
-
Singh N, Suarez JF, Avery R, Lass-Fl?rl C, Geltner C, Pasqualotto AC, Marshall Lyon G, Barron M, Husain S, Wagener MM, Montoya JG. Risk factors and outcomes in lung transplant recipients with nodular invasive pulmonary aspergillosis. J Infect. 2013 Jul; 67(1):72-8.
Score: 0.010
-
Ostrosky-Zeichner L, Pappas PG, Shoham S, Reboli A, Barron MA, Sims C, Wood C, Sobel JD. Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit. Mycoses. 2011 Jan; 54(1):46-51.
Score: 0.009
-
Sun HY, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N, John GT, Pursell KJ, Mu?oz P, Patel R, Fortun J, Martin-Davila P, Philippe B, Philit F, Tabah A, Terzi N, Chatelet V, Kusne S, Clark N, Blumberg E, Julia MB, Humar A, Houston S, Lass-Florl C, Johnson L, Dubberke ER, Barron MA, Lortholary O, Singh N. Pulmonary zygomycosis in solid organ transplant recipients in the current era. Am J Transplant. 2009 Sep; 9(9):2166-71.
Score: 0.008
-
Ning M, Furie KL, Koroshetz WJ, Lee H, Barron M, Lederer M, Wang X, Zhu M, Sorensen AG, Lo EH, Kelly PJ. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke. Neurology. 2006 May 23; 66(10):1550-5.
Score: 0.006
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|